Reading this on a mobile device? Try our optimized mobile version here:

October 10, 2012
Sign upForwardArchive
Your resource for current wound care information

  Wound Care Update 
  • Tissue Regenix reports positive interim trial results
    An experimental product based on animal tissue significantly reduced the surface area of chronic wounds after six weeks in a 20-patient trial, manufacturer Tissue Regenix reported. The dCELL Dermis technology involves stripping cellular material from animal tissue that would cause humans to reject the graft, creating a scaffold that encourages healthy cell growth. Full trial results are expected by the end of the year. Bloomberg Businessweek (10/4) LinkedInFacebookTwitterEmail this Story
  Research, Technology & Innovation 
  • Study: Polyhexanide/betaine solution reduces microbes in vitro
    A solution containing 0.1% polyhexanide and 0.1% betaine significantly reduced 12 of 13 microorganisms often found in chronic wounds in an in vitro study. Growth of Aspergillus brasiliensis was reduced, but not to the same extent as Staphylococcus epidermidis, Pseudomonas aeruginosa, Candida albicans, vancomycin-resistant Enterococcus faecalis, E. coli and methicillin-resistant Staphylococcus aureus, among other microorganisms. Ostomy Wound Management online (10/4) LinkedInFacebookTwitterEmail this Story
  • Researchers to test the effects of estrogen on wounds
    The hormone estrogen may encourage wound healing, which could explain why wounds tend to heal more slowly as people age, researchers at the University of Manchester's Healing Foundation Centre say. A clinical trial in the next few months will test the breast cancer drug tamoxifen's effects on wound healing. NetDoctor (U.K.) (10/3) LinkedInFacebookTwitterEmail this Story
  • Ethicon's knotless tissue control systems could arrive this fall
    Ethicon, a Johnson & Johnson unit, is preparing to launch its STRATAFIX line of knotless tissue control devices, which are intended to provide surgeons with more flexibility and control in creating tissue closures without the need for knots. The company plans to release the devices concurrently with the launch of its STRATAFIX Spiral systems later this fall. (10/5) LinkedInFacebookTwitterEmail this Story
  Health Policy & Regulation 
  • N.J. gets approval for Medicaid overhaul
    New Jersey received federal approval for a redesign of its Medicaid program that will give the state more flexibility in how it serves the elderly and people with disabilities. The plan calls for creating an incentive program for hospitals to improve quality of care, transfers long-term care services for the elderly to a managed care system and creates a managed care program for adults with mental illness. (Hackensack, N.J.) (10/6) LinkedInFacebookTwitterEmail this Story
Learn more about ADVTIS ->Advanced Tissue  |  Meet Our People
Placing An Order  |  Why Use Advanced Tissue
Our Philosophy  |  Facebook

The lure of the distant and the difficult is deceptive. The great opportunity is where you are."
--John Burroughs,
American naturalist and essayist

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Contact Advanced Tissue
7003 Valley Ranch Drive
Little Rock, Arkansas 72223
Quick Links
Why Use Advanced Tissue

Our Philosophy

Meet Our People

Placing An Order

About Advanced Tissue
Advanced Tissue is a leading wound care supply company offering a comprehensive line of wound care products from virtually all manufacturers. We understand the many obstacles associated with effective wound treatment and use this insight to provide the efficient delivery of dressings to enable enhanced compliance and improved patient outcomes. Advanced Tissue works with clinics throughout the U.S. and its territories to deliver a turnkey wound-supply solution for patients in the home setting as well as long-term care residents. Unit Dose Packaging provides a daily supply of advanced wound dressings packaged in an easy-open package. Our relationship with clinicians in the industry was forged on our innovative delivery model of Unit Dose Packaging and our commitment to not substituting product for financial gain. The ease and simplicity of this system has established Advanced Tissue as an invaluable partner in wound care.

 Recent Advanced Tissue SmartBrief Issues:   Lead Editor:  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information